PL401166A1 - Zlozony sorbent jelitowy - Google Patents

Zlozony sorbent jelitowy

Info

Publication number
PL401166A1
PL401166A1 PL401166A PL40116612A PL401166A1 PL 401166 A1 PL401166 A1 PL 401166A1 PL 401166 A PL401166 A PL 401166A PL 40116612 A PL40116612 A PL 40116612A PL 401166 A1 PL401166 A1 PL 401166A1
Authority
PL
Poland
Prior art keywords
intestinal
group
silicic acid
sorbent composite
sorbent
Prior art date
Application number
PL401166A
Other languages
English (en)
Inventor
Vadim Kozlovskyi
Yuriy Tolcheyev
Original Assignee
Vadim Kozlovskyi
Yuriy Tolcheyev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vadim Kozlovskyi, Yuriy Tolcheyev filed Critical Vadim Kozlovskyi
Publication of PL401166A1 publication Critical patent/PL401166A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Zlozony sorbent jelitowy oparty na polimerze wybranym z grupy obejmujacej kserozel kwasu metylokrzemowego lub hydrozel kwasu metylokrzemowego zawiera przynajmniej jeden polisacharyd wybrany z grupy obejmujacej, laktuloze, inuline, lignine, fruktooligosacharydy, kwas alginowy w postaci soli akceptowanych farmaceutycznie, chitosan, pektyne, gume arabska beta-glukan.
PL401166A 2011-11-23 2012-10-11 Zlozony sorbent jelitowy PL401166A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201113802A UA103089C2 (ru) 2011-11-23 2011-11-23 Композиционный энтеросорбент на основе кремниевого полимера

Publications (1)

Publication Number Publication Date
PL401166A1 true PL401166A1 (pl) 2013-05-27

Family

ID=48222154

Family Applications (1)

Application Number Title Priority Date Filing Date
PL401166A PL401166A1 (pl) 2011-11-23 2012-10-11 Zlozony sorbent jelitowy

Country Status (5)

Country Link
US (1) US20130129659A1 (pl)
CZ (1) CZ308038B6 (pl)
DE (1) DE102012109727A1 (pl)
PL (1) PL401166A1 (pl)
UA (1) UA103089C2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2591791C2 (ru) * 2014-09-30 2016-07-20 Александр Владимирович Диковский Композиция для детоксикации организма
UA112474C2 (uk) * 2014-11-20 2016-09-12 Юрій Захарович Толчеєв Спосіб одержання пастоподібного сорбенту на основі гідрогелю метилкремнієвої кислоти
RU2612011C1 (ru) * 2015-10-15 2017-03-01 государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный медицинский университет имени академика Е.А. Вагнера" Министерства здравоохранения Российской Федерации Энтеросорбент
CN113773989B (zh) * 2021-08-30 2023-06-13 大连工业大学 植物乳杆菌y12所产胞外多糖在缓解由福氏志贺氏菌引起痢疾病症的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2048123C1 (ru) 1991-12-10 1995-11-20 Николай Николаевич Терещенко Способ производства продукта для диетического питания
EP1306128A1 (en) * 2001-10-29 2003-05-02 Tenaxis Gmbh Sorptive composite materials
UA54103A (uk) 2002-05-14 2003-02-17 Львівський Державний Медичний Університет Ім. Данила Галицького Спосіб відновлення внутрішньокишкової флори у пацієнтів з гострим деструктивним панкреатитом в ранньому післяопераційному періоді
UA62152A (en) 2002-12-29 2003-12-15 Danylo Halytskyi Lviv State Ne Method for decreasing volume of intestinal evacuations and restoring intestinal microflora in patients with ileostoma at early postoperative stage
UA82774C2 (uk) * 2006-09-20 2008-05-12 Tolcheiev Yurii Zakharovych Спосіб одержання сорбенту на основі гідрогелю метилкремнієвої кислоти
PL2116564T3 (pl) * 2007-02-09 2014-07-31 Bioline Pharmaceutical Ag Absorbent i sposób jego wytwarzania
UA24987U (en) 2007-02-16 2007-07-25 Kyiv Nat Univ Tech & Design Drive of round-knitting machine
ITMI20071214A1 (it) * 2007-06-15 2008-12-16 S I I T Srl Servizio Internazi Composizioni a base di componenti prebiotici ed immunogenici per la prevenzione e il trattamento di disturbi gastroenterici da disbiosi e/o alterazioni della normale flora intestinale
RU2433751C2 (ru) * 2009-05-05 2011-11-20 Александр Владимирович Диковский Композиция для нормализации микрофлоры и очищения организма от токсинов и способ оздоровления организма
RU2455012C1 (ru) * 2011-01-11 2012-07-10 Учреждение Российской академии медицинских наук Научно-исследовательский институт медицинских проблем Севера Сибирского отделения РАМН Способ энтеральной детоксикации при лечении иммунных нарушений
UA64357U (ru) * 2011-03-16 2011-11-10 Алєксандр Владіміровіч Діковскій Композиция для очистки организма от токсинов и нормализации микрофлоры кишечника

Also Published As

Publication number Publication date
CZ2012706A3 (cs) 2013-06-05
US20130129659A1 (en) 2013-05-23
DE102012109727A1 (de) 2013-05-23
CZ308038B6 (cs) 2019-11-13
UA103089C2 (ru) 2013-09-10

Similar Documents

Publication Publication Date Title
BR112014028353A2 (pt) método de separação de hemicelulose e celulose a partir de fontes de polissacarídeo.
WO2014105984A3 (en) Implementing consistency groups with virtual machines
GB2554605B (en) Resynchronizing to a first storage system after failover to a second storage system mirroring first storage system
HK1218519A1 (zh) 透析系統
HRP20190122T1 (hr) Protutijelo protiv adrenomedulina (adm) ili fragment protutijela protiv adm ili okosnica ne-ig protiv adm, namijenjeni reguliranju ravnoteže tekućina kod pacijenta s kroničnom ili akutnom bolešću
BR112017000345A2 (pt) composições de oligossacarídeo e métodos para produção das mesmas
GB2501204B (en) Method for virtual machine failover management and system supporting the same
HUE044693T2 (hu) Fukozilezett oligoszaccharidok elõállitására alkalmazható alfa (1,2) fukoziltranszferázok
EP2939369A4 (en) ELASTIC DELIVERY OF PREFABRICATED COMPONENT VIRTUAL MACHINES TRAFFIC MANAGEMENT SYSTEM
TR201901968T4 (tr) Yeni̇lenmi̇ş selüloz elyaf.
EP2804680A4 (en) NETWORK GAME ARCHITECTURE, GAME SYSTEMS AND ASSOCIATED METHODS
FR2969577B1 (fr) Aeronef muni d'un rotor arriere basculant, et procede associe
WO2015056237A3 (en) Purification of proteins
PL401166A1 (pl) Zlozony sorbent jelitowy
FR2959898B1 (fr) Procede de lancement d'une conference a la volee mise en contexte.
GB2488983B (en) Suspended structure, scaffolding or framework system
BR112015005081A2 (pt) método para produzir um polissacarídeo capsular tendo um sorotipo de pneumococo
HK1203126A1 (en) Methods for providing sialylated oligosaccharides
EP2999778A4 (en) Common port emulsion generation system
MX348786B (es) Agentes osmoticos de polisacarido esterificado.
WO2015000933A3 (en) Microtissues
BR112015007740A2 (pt) método para obter alcoóis de açúcar tendo cinco ou seis átomos de carbono, a partir de material contendo celulose ou suas misturas
EP3316907A4 (en) CONTAINS OF BETA-1,6-GLUCAN AND ANTIBODY CÉTUXIMAB
EP2709322A4 (en) NODE ROUTING PROCESS FOR MORE PROCESSOR SYSTEM, CONTROL, AND MORE PROCESSOR SYSTEM
WO2011147886A3 (de) Einbau von filterkörpern in einen behälter